Indian PE giant ChrysCapital to invest $100m in drug maker Corona Remedies
Photo: Unsplash
Indian homegrown private equity (PE) major ChrysCapital is close to investing $100 million in Gujarat-based drug manufacturer Corona Remedies to help the latter fund its organic and inorganic expansion plans, DealStreetAsia has learnt.
Continue reading this story with a subscription to DealStreetAsia.
Already a subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com.
Bring stories like this into your inbox every day.
Sign up for our newsletter – The Daily Brief
Related Stories
The firm raised $300m from SoftBank in January 2020 at a reported valuation of $1.2b.
The deal sees Creador picking up a significant minority stake in the company.
